Conference call regarding Elekta’s Q3 report for 2018/19

STOCKHOLM, February 11, 2019 – Elekta (EKTA-B.ST) will publish its Q3 report for 2018/19 on February 22, as per:

  • The report will be published at 07:30 CET.
  • Elekta will host a telephone conference starting at 10:00 CET with Richard Hausmann, President and CEO, and Gustaf Salford, CFO.

To take part in the conference call, please dial in about five minutes in advance.

  • UK dial-in number: +44 (0) 333 300 9265
  • US dial-in number: +1 646 722 4902
  • Swedish dial-in number: +46 (0) 8 505 583 50

The telephone conference will also be broadcasted live online, through the following link (however, in order to ask questions, it is necessary to call in):
http://event.on24.com/wcc/r/1919136-1/CA7E707987FE9817758D6C8899341F6F 

# # #

For further information, please contact:
Oskar Bosson, Global EVP Corporate Communications and Investor Relations
Tel: +46 70 410 7180, E-mail: Oskar.Bosson@elekta.com
Time zone: CET: Central European Time

Gunilla Öhman, Head of Investor Relations (interim)
Tel: +46 70 763 8125, E-mail: gunilla.oehman@elekta.com
Time zone: CET: Central European Time

About Elekta
For almost five decades, Elekta has been a leader in precision radiation medicine. Our nearly 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to – and benefits from – more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter.

Tags:

About Us

For almost five decades, Elekta has been a leader in precision radiation medicine. Our nearly 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to – and benefits from – more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter.

Subscribe

Documents & Links